Carnelio Sunitha, Rodrigues Gabriel Sunil, Shenoy Rajgopal, Fernandes Donald
Indian J Surg. 2011 Aug;73(4):256-61. doi: 10.1007/s12262-011-0286-6. Epub 2011 Apr 28.
Long-term outcomes associated with oral cancer and its management over the past several decades has caused concern and the value of mass oral cancer screenings has come under scrutiny. Though not all oral carcinomas are preceded by premalignant lesions as clinically visible morphological alterations occur secondary to the cellular or molecular changes, certain high risk lesions have been identified. Their management remains controversially polarized between surgical excision to prevent malignant change and conservative medical or surveillance techniques. Though oral cancer is one of the "major killers" of modern times, there seem to be no widely accepted criteria for decision making in clinical practice, the evidence base is scanty and uncertainty persists throughout investigation, diagnosis, and treatment. In this article, we have briefly discussed the common premalignant lesions, with an emphasis on their evidence based management and prevention.
The online version of this article (doi:10.1007/s12262-011-0286-6) contains supplementary material, which is available to authorized users.
过去几十年来,口腔癌及其治疗的长期结果引发了关注,大规模口腔癌筛查的价值也受到了审视。尽管并非所有口腔癌都由癌前病变发展而来,因为临床可见的形态学改变是细胞或分子变化的继发结果,但已确定了某些高风险病变。其治疗在通过手术切除以预防恶变和采用保守的医学或监测技术之间仍存在争议性的两极分化。尽管口腔癌是现代的“主要杀手”之一,但临床实践中似乎没有广泛接受的决策标准,证据基础薄弱,在整个调查、诊断和治疗过程中不确定性依然存在。在本文中,我们简要讨论了常见的癌前病变,重点是基于证据的管理和预防。
本文的在线版本(doi:10.1007/s12262-011-0286-6)包含补充材料,授权用户可获取。